These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11316683)

  • 1. An auditable protocol for treating attention deficit/hyperactivity disorder.
    Hill P; Taylor E
    Arch Dis Child; 2001 May; 84(5):404-9. PubMed ID: 11316683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
    Gross MD
    Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283
    [No Abstract]   [Full Text] [Related]  

  • 3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food additives and hyperactivity.
    Palmer S; Rapoport JL; Quinn PO
    Clin Pediatr (Phila); 1975 Oct; 14(10):956-9. PubMed ID: 1100297
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychotropic drugs for children].
    Nissen G
    MMW Munch Med Wochenschr; 1981 Feb; 123(7):245-6. PubMed ID: 6780896
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating attention-deficit hyperactivity disorder: medication and behavior management training.
    Barkley RA; Murphy JV
    Pediatr Ann; 1991 May; 20(5):256-60, 263, 266. PubMed ID: 1896228
    [No Abstract]   [Full Text] [Related]  

  • 9. European clinical guidelines for hyperkinetic disorder -- first upgrade.
    Taylor E; Döpfner M; Sergeant J; Asherson P; Banaschewski T; Buitelaar J; Coghill D; Danckaerts M; Rothenberger A; Sonuga-Barke E; Steinhausen HC; Zuddas A
    Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I7-30. PubMed ID: 15322953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit hyperactivity disorder in adults: diagnosis, treatment, and prognosis.
    Fargason RE; Ford CV
    South Med J; 1994 Mar; 87(3):302-9. PubMed ID: 8134849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hyperactive child.
    Chapel JL
    Mo Med; 1973 Nov; 70(11):768-74. PubMed ID: 4753031
    [No Abstract]   [Full Text] [Related]  

  • 12. Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia.
    Al-Haidar FA
    East Mediterr Health J; 2003; 9(5-6):988-95. PubMed ID: 16450529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive management of the hyperkinetic child.
    Renshaw D
    Aust Fam Physician; 1976 Oct; 5(9):1289-90, 1293-4, 1297 passim. PubMed ID: 1008743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder.
    Sudnawa KK; Chirdkiatgumchai V; Ruangdaraganon N; Khongkhatithum C; Udomsubpayakul U; Jirayucharoensak S; Israsena P
    Pediatr Int; 2018 Sep; 60(9):828-834. PubMed ID: 29931709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quality of life of children and adolescents with ADHD undergoing outpatient psychiatric treatment: simple disorders of activity and attention and hyperkinetic conduct disorders in comparison with each other and with other diagnostic groups.
    Remschmidt H; Mattejat F
    Atten Defic Hyperact Disord; 2010 Dec; 2(4):161-70. PubMed ID: 21432603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
    CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The hyperkinetic syndrom in childhood (author's transl)].
    Nissen G
    Monatsschr Kinderheilkd (1902); 1974 Sep; 122(9):790-3. PubMed ID: 4612349
    [No Abstract]   [Full Text] [Related]  

  • 19. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial.
    Meppelink R; de Bruin EI; Bögels SM
    BMC Psychiatry; 2016 Jul; 16():267. PubMed ID: 27460004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.